SABCS 2022 Conference Coverage
Playback speed
10 seconds
SABCS 2022 Primary Results From the Randomized Phase II RIGHT Choice Trial: Premenopausal Patients With Aggressive HR+/HER2- Advanced BC Treated With Ribociclib + ET vs. Physician’s Choice Combination Chemo
By
SABCS 2022 Conference Coverage
FEATURING
Yen-Shen Lu
By
SABCS 2022 Conference Coverage
FEATURING
Yen-Shen Lu
212 views
January 20, 2023
Comments 0
Login to view comments.
Click here to Login
Videos